pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Cardiology · news · pharmadog
← back to Cardiology
News · Cardiology
591
stories
7d
Trump uses ‘contested’ power to cut more funding to HHS
stat
7d
Kids shouldn’t have to organize childhood around medicine
biopharma dive
7d
Opinion: I discovered a new structure in the heart — just by looking closely
stat
7d
Opinion: AI is eroding the barriers that kept biological weapons rare
stat
7d
Regenerative medicine needs more than stem cells
biospace
9d
Opinion: I worked on the CDC investigation of the anthrax letters. 25 years later, are we ready for the next biothreat?
stat
10d
Opinion: FDA commissioner nominee Heidi Overton is ignoring the science on abortion drug
stat
10d
ADARx raises $446M in biotech’s third largest IPO of 2026, City files to go public
biospace
10d
Federal judge rolls back landmark disability protections
stat
10d
Genentech makes $1.5B+ deal with AI heavyweight Earendil for cancer bispecifics
biospace
10d
Opinion: The ‘died with’ vs. ‘died of’ measles discussion misses something very important
stat
10d
Opinion: RFK Jr.’s use of the National Center for Health Statistics will add confusion to measles deaths count
stat
11d
Merck reveals study success, and possible safety worries, for eye drug hopeful
biopharma dive
11d
Acadia slides on Phase 2 miss in Alzheimer’s psychosis but keeps moving asset forward
biospace
11d
Eli Lilly’s weekly insulin shot cleared by FDA, setting up another front in Novo rivalry
biospace
11d
Roche inks up to $2B deal with Atavistik for new cardiometabolic drugs
biospace
11d
Opinion: STAT+: A moment of reckoning for preventive cardiology and the precision medicine revolution
stat
11d
Opinion: Measles almost killed me. Now I’m a doctor — and I’m scared of what’s happening
stat
11d
Roche pens backloaded $2B deal with Atavistik to discover allosteric CVRM drugs
fiercebiotech
11d
Adagio Medical kicks off strategic review, trims more than half its staff
fiercebiotech
11d
Heart Pump Controller Recall: Abiomed Removes Automated Impella Controllers
fda medwatch
11d
Growth mode: 3 biotechs that are staffing up after series B raises
biospace
12d
New approach methodologies in safety and toxicology testing: Why proving repeatability is the next hurdle for widespread adoption
fiercebiotech
12d
Roche-Ionis’ RNA therapy reduces kidney disease marker, opening path to swift FDA nod
biospace
12d
Ionis-Otsuka offer 'groundbreaking' improvement in function and survival for genetic type of ALS
biospace
12d
Boehringer adds $250M to value of Variant pact by expanding into cardiovascular disease
fiercebiotech
12d
STAT+: UnitedHealth, CVS push back on Medicare plan to curb remote patient monitoring
stat
12d
9 companies hiring in Pennsylvania now
biospace
12d
Early Alert: Heart Pump Controller Issue from Abiomed
fda medwatch
12d
Roche’s phase 3 win tees up fight with Novartis for blockbuster kidney disease market
fiercebiotech
← prev
page 2 of 20
next →
